Расстроенная психика. Что рассказывает о нас необычный мозг

⁸² Snyder A. Explaining and inducing savant skills: privileged access to lower level, less-processed information. Philosophical Transactions of the Royal Society B: Biological Sciences. 2009; 1522: 1399–1405.

⁸³ Kontos P. The painterly hand: rethinking creativity, selfhood, and memory in dementia. Workshop 4: memory and/in late-life creativity. London: King’s College, 2012.

⁸⁴ Miller B. L. et al. Enhanced artistic creativity with temporal lobe degeneration. Lancet. 1996; 9043: 1744–1745.

⁸⁵ Hylton W. S. The mysterious metamorphosis of Chuck Close. The New York Times Magazine. 2016 (https://www.nytimes.com/2016/07/17/magazine/the-mysterious-metamorphosis-of-chuck-close.html).

⁸⁶ Arnheim R. The artistry of psychotics // To the rescue of art: twenty-six essays. Berkeley: University of California Press, 1992.

⁸⁷ Power R. A. et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nature Neuroscience. 7: 953–955.

⁸⁸ Sample I. New study claims to find genetic link between creativity and mental illness. The Guardian. 2015 (www.theguardian.com/science/2015/jun/08/new-study-claims-to-find-genetic-link-between-creativity-and-mental-illness).

⁸⁹ Sherrington C. S. The integrative action of the nervous system. New Haven, CT: Yale University Press, 1906.

⁹⁰ Parkinson J. An essay on the shaking palsy. 1817. Journal of Neuropsychiatry and Clinical Neurosciences. 2002; 2: 223–236.

⁹¹ Carlsson A., Lindqvist M., Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957; 4596: 1200.

⁹² Carlsson A. Biochemical and pharmacological aspects of parkinsonism. Acta Neurologica Scandinavica, Supplementum. 1972; 51: 11–42.

⁹³ Carlsson A., Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. Journal of Neural Transmission. 1976; 3–4: 271–276.

⁹⁴ Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism and Related Disorders. 1998; 2: 53–57.

⁹⁵ Cotzias G. C., Van Woert M. H., Schiffer L. M. Aromatic amino acids and modification of parkinsonism. New England Journal of Medicine. 1967; 7: 374–379.

⁹⁶ Bergman H., Wichmann T., DeLong M. R. Reversal of experimental parkinsonism by lesions of the supthalamic nucleus. Science. 1990; 249: 1436–1438.

⁹⁷ DeLong M. R. Primate models of movement disorders of basal ganglia origin. Trends in Neurosciences. 1990; 7: 281–285.

⁹⁸ Housman D., Gusella J. R. Application of recombinant DNA techniques to neurogenetic disorders. Research Publications – Association for Research in Nervous and Mental Disorders. 1983; 60: 167–172.

⁹⁹ The Huntington’s disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993; 72: 971–983.

¹⁰⁰ Prusiner S. B. Novel proteinaceous infectious particles cause scrapie. Science. 1982; 4542: 136–144.

¹⁰¹ Prusiner S. B. Madness and memory: the discovery of prions – a new biological principle of disease. New Haven, CT: Yale University Press, 2014.

¹⁰² Feany M. B., Bender W. W. A drosophila model of Parkinson’s disease. Nature. 2000; 6776: 394–398.

¹⁰³ James W. What is an emotion? Mind. 1884; 34: 190.